Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huamin Han

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos One|October 3, 2013
Retargeting T cells for HER2-positive tumor killing by a bispecific Fv-Fc antibodyLei Wang, Yanran He, Ge Zhang, et al.
International Journal of Oncology|September 23, 2014
Bispecific anti-CD3 x anti-HER2 antibody mediates T cell cytolytic activity to HER2-positive colorectal cancer in vitro and in vivoHuamin Han, Juan Ma, Keming Zhang, et al.
Plos One|September 10, 2013
HER2 as a promising target for cytotoxicity T cells in human melanoma therapyJuan Ma, Huamin Han, Deruo Liu, et al.
Scientific Reports|January 7, 2014
Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptorGe Zhang, Lei Wang, Honglian Cui, et al.
Immunology and Cell Biology|October 9, 2013
Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibodyGe Zhang, Rongzhi Liu, Xuekai Zhu, et al.
FEBS Letters|August 20, 2013
Inhibition effect of enteropeptidase on RANKL-RANK signalling by cleavage of RANKYunfeng Zhao, Mengmeng Jin, Juan Ma, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|October 3, 2013
Retargeting T cells for HER2-positive tumor killing by a bispecific Fv-Fc antibodyLei Wang, Yanran He, Ge Zhang, et al.
International Journal of Oncology|September 23, 2014
Bispecific anti-CD3 x anti-HER2 antibody mediates T cell cytolytic activity to HER2-positive colorectal cancer in vitro and in vivoHuamin Han, Juan Ma, Keming Zhang, et al.
Plos One|September 10, 2013
HER2 as a promising target for cytotoxicity T cells in human melanoma therapyJuan Ma, Huamin Han, Deruo Liu, et al.
Scientific Reports|January 7, 2014
Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptorGe Zhang, Lei Wang, Honglian Cui, et al.
Immunology and Cell Biology|October 9, 2013
Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibodyGe Zhang, Rongzhi Liu, Xuekai Zhu, et al.
FEBS Letters|August 20, 2013
Inhibition effect of enteropeptidase on RANKL-RANK signalling by cleavage of RANKYunfeng Zhao, Mengmeng Jin, Juan Ma, et al.
Pageof 2